Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy-Reference-Cited by-同舟云学术

Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy

Published:2022-12 Issue: Volume:68 Page:104195
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Bazzi Sam A.,Maguire Cole,Holay Nisha,Geltman Janelle,Hurley Kerin,DiPasquale Chris,Abigania Melissa,Olson Eric,Ehrlich Lauren I.R.,Triplett Todd A.,Melamed Esther

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference41 articles.

1. Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy;Apostolidis;Nat. Med.,2021

2. Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy;Apostolidis;Nat. Med.,2021

3. Differential expression of IgM and IgD discriminates two subpopulations of human circulating IgM+IgD+CD27+ B cells that differ phenotypically, functionally, and genetically;Bautista;Front. Immunol.,2020

4. B cells as target for immunotherapy in rheumatic diseases–current status;Bryl;Immunol. Lett.,2021

5. B cell depleters attenuate the humoral response to SARS-CoV-2 vaccines in multiple sclerosis patients: a case-control study;Conte;Mult. Scler. Relat. Disord.,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 Humoral Immune Responses in Convalescent Individuals Over 12 Months Reveal Severity-Dependent Antibody Dynamics;2023-12-07